Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Neoantigen-targeted TCR-engineered T cell immunotherapy: current advances and challenges
Zhi Pang, Manman Lu, Yu Zhang, et al.
Biomarker Research (2023) Vol. 11, Iss. 1
Open Access | Times Cited: 23

Showing 23 citing articles:

Emerging Therapeutic Strategies to Overcome Drug Resistance in Cancer Cells
Pankaj Garg, Jyoti Malhotra, Prakash Kulkarni, et al.
Cancers (2024) Vol. 16, Iss. 13, pp. 2478-2478
Open Access | Times Cited: 11
Heterogeneity and molecular landscape of melanoma: implications for targeted therapy
Yasaman Zohrab Beigi, Hossein Lanjanian, Reyhane Fayazi, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 6
Personalized, autologous neoantigen-specific T cell therapy in metastatic melanoma: a phase 1 trial
Jessica S.W. Borgers, Divya Lenkala, Victoria Kohler, et al.
Nature Medicine (2025)
Open Access
Hybrid lipid nanoparticles with tumor antigen-primed dendritic cell membranes for post-surgical tumor immunotherapy
Dongyoon Kim, Jiwon Choi, D-H Jin, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 537-548
Closed Access
Therapeutic role of immune cells against colon cancer
Manoj Kumar Gupta, Gayatri Gouda, Ramakrishna Vadde
Elsevier eBooks (2025), pp. 127-146
Closed Access
Neoantigen mRNA vaccines and A 2 A receptor antagonism: A strategy to enhance T cell immunity
Saber Imani, Parham Jabbarzadeh Kaboli, Ali Babaeizad, et al.
Human Vaccines & Immunotherapeutics (2025) Vol. 21, Iss. 1
Open Access
Technical pitfalls when collecting, cryopreserving, thawing, and stimulating human T-cells
Daniel J. Browne, Catherine Miller, Denise L. Doolan
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Neoantigens in cancer immunotherapy: focusing on alternative splicing
Peng Huang, Feng Wen, Nuerye Tuerhong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
mRNA vaccines in tumor targeted therapy: mechanism, clinical application, and development trends
Yu Gao, Liang Yang, Zhenning Li, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 4
Application of biomimetic nanovaccines in cancer immunotherapy: A useful strategy to help combat immunotherapy resistance
Zhijie Xu, Zhou Hai-yan, Tongfei Li, et al.
Drug Resistance Updates (2024) Vol. 75, pp. 101098-101098
Closed Access | Times Cited: 3
Advances in targeting tumor microenvironment for immunotherapy
Lugang Wang, Liubo Zhang, Zhen Zhang, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Harnessing neoantigen-specific T cells for precision cancer immunotherapy
Marco Donia, Inge Marie Svane
Nature Reviews Clinical Oncology (2024) Vol. 21, Iss. 4, pp. 253-254
Closed Access | Times Cited: 2
Current Treatment Options for Renal Cell Carcinoma: Focus on Cell-Based Immunotherapy
Angela Hwang, Vedika Mehra, Jyoti Chhetri, et al.
Cancers (2024) Vol. 16, Iss. 6, pp. 1209-1209
Open Access | Times Cited: 2
TCR-T cell therapy: current development approaches, preclinical evaluation, and perspectives on regulatory challenges
Elena A. Golikova, Alina Alshevskaya, Saleh Alrhmoun, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Ezrin's role in gastric cancer progression: Implications for immune microenvironment modulation and therapeutic potential
Yanli Zhu, Xue Zhang, Yi Chen, et al.
Heliyon (2024) Vol. 10, Iss. 5, pp. e27155-e27155
Open Access | Times Cited: 1
Llama-TCR: Generate De Novo TCR with Large Language Model
Zhou Jun, Zhenhua Wu, Mengren Man, et al.
(2024), pp. 845-850
Closed Access | Times Cited: 1
Immunotherapy for gastric cancer: Advances and challenges
Pei Zhang, Chenyan Zhang, M Kellis, et al.
MedComm – Oncology (2024) Vol. 3, Iss. 4
Open Access | Times Cited: 1
Personalized nanovaccines for treating solid cancer metastases
Feng Tang, Jia Hu, Jirui Wen, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
An ion channel-based prognostic model identified TRPV2 and GJB3 as immunotherapy determinants in pancreatic cancer
Jiakai Mao, Yu Tian, Nan Luo
Heliyon (2024) Vol. 10, Iss. 7, pp. e27301-e27301
Open Access
Engineered Cellular Immunotherapy for Cancer
Nikita Trivedi
IntechOpen eBooks (2024)
Open Access
Novel immunotherapeutic approaches in gastric cancer
Meng Yang, Wuhao Lin, Jiaqian Huang, et al.
Precision Clinical Medicine (2024) Vol. 7, Iss. 4
Open Access
Crossing the Blood-Brain Barrier: Advancing Immunotherapy for Pediatric Brain Tumors
Nima Taghizadeh Mortezaei, Adrina Habibzadeh, Zahra Rahimian, et al.
Interdisciplinary cancer research (2024)
Closed Access
Physiological markers for immunotherapeutics: a review
Durlav Chowdhury, Ashmita Das, Mrityunjay Mishra, et al.
Journal of Chemotherapy (2024), pp. 1-24
Closed Access
Facilitation Of Antigen Targeting for Tumor Vaccines Using Artificial Intelligence
Jiaming Cui
Highlights in Science Engineering and Technology (2024) Vol. 123, pp. 211-218
Closed Access
Page 1

Scroll to top